A new clinical trial showed promising results in curbing alcohol cravings in individuals with moderate alcohol-use disorder.
Although the first GLP-1 drug was approved by the US Food and Drug Administration (FDA) in the early 2000s, it wasn't until a ...
GLP-1 medications initially were used to help people with diabetes improve their insulin resistance and hunger cravings.
Eli Lilly continues to see strong growth coming from its GLP-1 drugs. The company's current 2025 guidance looks conservative.
Treatment for OUD is currently dominated by opioid agonist therapies that are highly regulated due to their liability for abuse.
This article showcases a curated list of standout studies over the last week on topics such as cholesterol, GLP-1 drugs for ...
Novo Nordisk only prices in management's latest year guidance and underestimates the full market potential. See why I rate ...
Scientists have discovered an antibody treatment that may help prevent both muscle loss and bone density loss in people using ...
When Trova Wine and Market shut its doors last month after nearly five years in Dallas, owner Michelle Bonds pointed to an unexpected reason for closure: GLP-1 weight loss drugs like Ozempic.
Related Cosmetic surgeons try to correct 'Ozempic face' for weight-loss drug users Massive study looks at benefits, risks of ...
ORLANDO, FLA. — Increasing levels of protein and fiber, stressing portion control, and adding savory flavors are ways that ...
GLP-1 medications initially were used to help people with diabetes improve their insulin resistance and hunger cravings.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results